Abstract:Diseases caused by rhabdoviruses have had a huge impact on the productive lives of the entire human population. The main problem is the lack of drugs for the treatment of this family of viruses. Infectious hematopoietic necrosis virus (IHNV), the causative agent of IHN, is a typical rhabdovirus which has caused huge losses to the salmonid industry. Therefore, in this study, IHNV was studied as a model to evaluate the antiviral activity of 35 novel coumarin derivatives. Coumarin A9 was specifically selected for further validation studies upon comparing the half maximum inhibitory concentration (IC50) of four screened candidate derivatives in epithelioma papulosum cyprinid (EPC) cells, as it exhibited an IC50 value of 2.96 μM against IHNV. The data revealed that A9 treatment significantly suppressed the virus-induced cytopathic effect (CPE) in EPC cells. In addition, A9 showed IC50 values of 1.68 and 2.12 μM for two other rhabdoviruses, spring viremia of carp virus and micropterus salmoides rhabdovirus, respectively. Furthermore, our results suggest that A9 exerts antiviral activity, but not by destroying the virus particles and interfering with the adsorption of IHNV. Moreover, we found that A9 had an inhibitory effect on IHNV-induced apoptosis in EPC cells, as reflected by the protection against cell swelling, formation of apoptotic bodies, and loss of cell morphology and nuclear division. There was a 19.05 % reduction in the number of apoptotic cells in the A9 treatment group compared with that in the IHNV group. In addition, enzyme activity assays proved that A9 suppressed the expression of caspase 3, 8 and 9. These results suggested that A9 inhibit viral replication, to some extent, by blocking IHNV-induced apoptosis. In an in vivo study, A9 exhibited an anti-rhabdovirus effect in virus-infected fish by substantially enhancing the survival rate. Consistent with the above results, A9 repressed IHNV gene expression in virus-sensitive tissues (brain, kidney and spleen) in the early stages of virus infection. Importantly, the data showed that horizontal transmission of IHNV was reduced by A9 in a static cohabitation challenge model, especially in fish that underwent bath treatment, suggesting that A9 might be a suitable therapeutic agent for IHNV in aquaculture. Therefore, coumarin derivatives can be developed as antiviral agents against rhabdoviruses.

In vitro and in vivo inhibition of a novel arctigenin derivative on aquatic rhabdovirus

4′-(8-imidazole-octyloxy)-arctigenin efficiently inhibits spring viraemia of carp virus infection in vitro and in vivo

Evaluation on antiviral activity of a novel arctigenin derivative against multiple rhabdoviruses in aquaculture

Synthesis and in Vitro Activities Evaluation of Arctigenin Derivatives Against Spring Viraemia of Carp Virus

Evaluation on the antiviral effect of natural product arctigenin against Micropterus salmoides rhabdovirus (MSRV) in vitro and in vivo

Synthesis and Antiviral Activity of a New Arctigenin Derivative Against IHNV in Vitro and in Vivo.

Antiviral Activity of Anisomycin Against Spring Viraemia of Carp Virus in Epithelioma Papulosum Cyprini Cells and Zebrafish

Evaluation on the Antiviral Activity of Artemisinin Against Rhabdovirus Infection in Common Carp

Schisandrin A: A sustainable antiviral and immunomodulatory agent against spring viraemia of carp virus in aquaculture

Antiviral innovations in largemouth bass aquaculture: Unveiling the potential of arctigenin derivatives against Micropterus Salmoides rhabdovirus

Inhibition of Fish Rhabdovirus Demonstrates Application Prospect of Two Methylimidazole Phenylpropanoid-Based Small Molecules in Aquaculture

Therapeutic potential of phenylpropanoid-based small molecules as anti-SVCV agents in aquaculture

4'-(8-(4-Methylimidazole)-octyloxy)-arctigenin: The first inhibitor of fish rhabdovirus glycoprotein

A therapeutic agent of ursolic acid demonstrates potential application in aquaculture

Immune responses and protective efficacy on 4-(2-methoxyphenyl)-3,4-dihydro-2H-chromeno[4,3-d] pyrimidine-2,5 (1H)-dione against spring viremia of carp virus in vivo

Synthesis and biological evaluation of novel coumarin derivatives in rhabdoviral clearance

Potential prospect of a therapeutic agent against spring viraemia of carp virus in aquaculture

Hydroxycoumarin efficiently inhibits spring viraemia of carp virus infection in vitro and in vivo

In vitro and in vivo evaluation of antiviral activity of a phenylpropanoid derivative against spring viraemia of carp virus

Evaluation on the Antiviral Activity of Bacillus Velezensis Extract Against Spring Viremia of Carp Virus

In vitro antiviral efficacy of moroxydine hydrochloride and ribavirin against grass carp reovirus and giant salamander iridovirus.